Localized prostate cancer
Patients with cancer confined to the prostate may consider surgery, radiation, or active surveillance depending on risk group.
Oncology procedure guide
Prostate cancer surgery usually means radical prostatectomy, where the prostate and seminal vesicles are removed and lymph nodes may be sampled. It is considered for selected localized or locally advanced prostate cancer when the patient is fit for anesthesia and understands urinary, sexual, pathology, and follow-up implications. Indian hospitals commonly offer open, laparoscopic, and robotic approaches, but the right plan depends on PSA, Gleason grade, MRI, PSMA PET, urinary symptoms, age, health, and personal priorities.
Who may be suitable for prostate cancer surgery?
Surgery may suit patients with cancer that appears confined to the prostate or selected nearby spread where complete removal is realistic. It is compared with radiation, hormone therapy, active surveillance, or combined treatment using PSA, biopsy grade group, MRI findings, PSMA PET, life expectancy, urinary function, sexual function, and patient preference. A urologic oncologist should explain cancer control and quality-of-life tradeoffs clearly.
Candidate fit
Patients with cancer confined to the prostate may consider surgery, radiation, or active surveillance depending on risk group.
Surgery may be part of treatment, but lymph node assessment and possible additional therapy should be discussed.
Some patients choose surgery because it provides full gland pathology and PSA should become very low after removal.
Age, heart health, diabetes, obesity, prior abdominal surgery, urinary symptoms, and sexual function affect planning.
What it treats
Radical prostatectomy removes the prostate when imaging and staging suggest the disease is removable.
Selected patients with extension near the capsule or seminal vesicles may still be considered for surgery as part of multimodal care.
Surgery planning must distinguish cancer control from urinary symptom treatment because radical prostatectomy is not the same as TURP.
Patients on active surveillance may move to treatment if PSA, MRI, or biopsy findings show progression.
Procedure approach
Technique choice can affect cost, hospital stay, recovery speed, risk profile, and follow-up requirements.
Approach affects incision, cost, recovery, and surgeon ergonomics, but cancer clearance and functional outcomes matter most.
Robotic surgery uses small incisions and a console-guided platform, often chosen for precision around nerves and urinary reconstruction.
Keyhole surgery without the robotic platform can be appropriate in experienced hands and may cost less than robotic surgery.
Open surgery remains an option in selected cases, especially where anatomy, prior surgery, cost, or surgeon expertise supports it.
Quality-of-life counselling should happen before the operation, not after a complication appears.
Nerve-sparing may support erectile recovery in selected patients but must not compromise cancer clearance when the tumor is close to the capsule.
Intermediate or high-risk disease may require lymph node removal for staging and treatment planning.
Pre- and post-surgery pelvic-floor exercises can help continence recovery when taught correctly.
Reports before planning
Reports help doctors confirm whether the procedure is suitable and what can change the treatment plan after arrival.
Preparation
Ask the urologic oncologist to explain low, intermediate, or high-risk classification and why surgery is preferred or optional.
A confident plan should compare surgery with radiation, hormone therapy, active surveillance, or combined treatment when relevant.
The surgeon should explain expected urine leakage recovery, erectile-function changes, and rehabilitation options.
International patients should not plan return travel until catheter care, leak test if used, and early follow-up are clear.
Hospital stay
The team confirms imaging, biopsy, anesthesia fitness, blood thinner plan, bowel preparation if used, and consent.
The prostate and seminal vesicles are removed, the bladder is reconnected to the urethra, and nodes may be removed.
Patients learn catheter care, drain monitoring if used, walking, pain control, and warning signs.
Final pathology reports margins, grade, stage, seminal vesicle involvement, and nodes, guiding PSA monitoring or further therapy.
Recovery
Catheter care, walking, bowel function, pain control, hydration, and wound checks are the priorities.
After catheter removal, patients focus on continence exercises, gradual activity, and avoiding heavy strain.
PSA is checked to confirm response, while urine control and sexual rehabilitation continue.
Regular PSA testing is essential because a rising PSA after surgery can signal recurrence and need further treatment.
Risks and safety questions
Leakage can occur after catheter removal and may improve over months, but some patients need longer rehabilitation.
Ask about expected recovery.
Nerve injury, cancer extent, age, and baseline function affect erectile recovery.
Nerve-sparing is not always safe.
Cancer at the cut edge can increase recurrence risk and may lead to radiation discussion.
Final pathology decides.
Pelvic surgery carries risks of infection, bleeding, urinary leak, and blood clots.
Early walking and instructions matter.
High-risk pathology may require radiation, hormone therapy, or close PSA surveillance.
Surgery may not be the last step.
India advantages
Major Indian hospitals offer robotic prostatectomy with urologic oncology teams and pathology support.
MRI prostate and PSMA PET can be integrated into staging and surgical planning in leading centers.
Robotic costs vary across Delhi NCR, Mumbai, Chennai, Bangalore, Hyderabad, Gurgaon, Ahmedabad, Pune, and selected Tier 2 cities.
Virello can help plan catheter timing, hotel stay, PSA follow-up, pathology review, and remote communication after return.
Cost range and variables
Prostate cancer surgery can range around $5,500-$14,500+, with robotic platform, hospital city, lymph node dissection, and imaging changing cost.
Radiation or hormone therapy is separate.
Robotic surgery usually costs more because of platform charges and disposables, while laparoscopic or open routes may be lower.
Choose by case fit and surgeon skill.
MRI, PSMA PET, pathology review, and biopsy slide review can add cost but strongly affect treatment selection.
These are often worth planning.
Delhi NCR, Mumbai, Chennai, Bangalore, Hyderabad, and Gurgaon have deeper robotic programs; Ahmedabad, Pune, Jaipur, Indore, Bhopal, and Coimbatore may suit selected cases.
Follow-up access matters.
Pelvic-floor therapy, catheter supplies, medicines, and longer local stay can add to total trip cost.
Budget beyond surgery.
Hospital selection
Choose hospitals with prostate cancer volume, robotic or laparoscopic expertise, pathology, imaging, and radiation oncology backup.
Cancer and function both matter.
High-quality staging prevents wrong treatment selection and helps plan nerve-sparing or node removal.
Images should be reviewed directly.
International patients need clear catheter removal timing, emergency contact, and leak or wound follow-up.
This shapes travel dates.
High-risk patients should have radiation and medical oncology access if pathology suggests additional treatment.
Plan the full pathway.
Doctor selection
Ask about robotic or laparoscopic volume, nerve-sparing judgement, margin rates, lymph node dissection, and continence outcomes.
Before surgery, selected patients should hear whether radiation would offer a reasonable alternative.
This improves consent quality.
The doctor should explain Gleason grade, margins, stage, nodes, and PSA follow-up in practical terms.
Families need clear next steps.
Ask who will guide pelvic-floor exercises, erectile rehabilitation, catheter care, and follow-up after return home.
Recovery is not automatic.
Questions
Yes. Many major Indian hospitals offer robotic radical prostatectomy, but the right choice depends on surgeon experience, cancer stage, anatomy, cost, and patient priorities.
A broad planning range is about $5,500-$14,500+, with robotic platform, hospital city, imaging, lymph node dissection, and recovery needs affecting the estimate.
Some leakage is common after catheter removal and often improves over time. Age, baseline function, technique, and pelvic-floor rehabilitation influence recovery.
No. Nerve-sparing is considered when cancer location and stage allow it. If cancer is close to the nerves, preserving them may increase cancer-clearance risk.
Many patients need 2-3 weeks for surgery, catheter care, pathology review, and early follow-up, but timing depends on recovery and doctor protocol.
PSMA PET is often used for staging in intermediate or high-risk prostate cancer, but the need depends on PSA, Gleason grade, MRI findings, and doctor assessment.
Selected cases can compare Tier 2 hospitals, especially if the surgeon is experienced and imaging/pathology support is reliable. Complex high-risk cases may fit metro centers better.
Yes. Virello can help organize urology, radiation oncology, and medical oncology reviews, plus cost and city comparisons.
Continue planning
Compare surgery, radiation, hormone therapy, imaging, and follow-up costs.
Review radiation as an alternative or follow-up treatment.
Compare robotic platform planning, surgeon volume, and recovery logistics.
Prepare cancer staging, treatment sequence, and follow-up questions.
Compare urinary, prostate, and robotic-care questions before procedure selection.
Compare a major robotic and oncology destination.
Share PSA, biopsy, MRI, PSMA PET, and treatment records.